Silverman Stuart L
University of California, Los Angeles, 8641 Wilshire Blvd., Suite 301, Beverly Hills, CA 90211, USA.
Curr Osteoporos Rep. 2006 Sep;4(3):91-5. doi: 10.1007/s11914-996-0027-0.
There is a global need to identify individuals at risk for osteoporotic fracture so that those at high risk can be treated and unnecessary treatment for those at low risk can be avoided. Bone mineral density (BMD) information is not sufficient to identify patients at high risk; approximately half of patients in the community with fractures do not have osteoporosis by the 1994 World Health Organization BMD criteria. Furthermore, BMD information is not easily accessible worldwide. The use of clinical risk factors with or without BMD information will improve our ability to identify patients at high risk for fracture. These risk factors can be integrated to predict a 10-year absolute risk or probability of fracture. Intervention thresholds based on absolute risk will be defined regionally based on each nation's ability and willingness to pay.
全球都需要识别有骨质疏松性骨折风险的个体,以便对高危个体进行治疗,并避免对低危个体进行不必要的治疗。骨密度(BMD)信息不足以识别高危患者;根据1994年世界卫生组织的骨密度标准,社区中约一半骨折患者没有骨质疏松症。此外,骨密度信息在全球范围内不易获取。使用临床风险因素(无论是否有骨密度信息)将提高我们识别骨折高危患者的能力。这些风险因素可以整合起来预测10年绝对骨折风险或概率。基于绝对风险的干预阈值将根据每个国家的支付能力和意愿在地区层面进行定义。